Ligand-functionalized nanoliposomes for targeted delivery of galantamine

International Journal of Pharmaceutics

Volumn 448, Issue 1, 2013, Pages 267-281

  Mufamadi, Maluta S ^a   Choonara, Yahya E ^a   Kumar, Pradeep ^a   Modi, Girish ^b   Naidoo, Dinesh ^a   Van Vuuren, Sandy ^a   Ndesendo, Valence M K ^c   Toit, Lisa C Du ^a   Iyuke, Sunny E ^d   Pillay, Viness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c ST JOHN'S UNIVERSITY OF TANZANIA   (Tanzania)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Alzheimer's disease (AD); Galantamine; In silico molecular modeling analysis; Intracellular delivery; Ligand functionalized nanoliposomes; Targeting peptides

Indexed keywords

GALANTAMINE;

ALZHEIMER DISEASE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLUOROMETRY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; MOLECULAR MECHANICS; PARTICLE SIZE; PC12 CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ANIMALS; GALANTAMINE; LIGANDS; LIPIDS; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NOOTROPIC AGENTS; OLIGOPEPTIDES; PC12 CELLS; RATS; SURFACE PROPERTIES;

EID: 84875929828     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.037     Document Type: Article

References (63)

1. A. Accardo, G. Salsano, A. Morisco, M. Aurilio, A. Parisi, F. Maione, C. Cicala, D. Tesauro, L. Aloj, G. De Rosa, and G. Morelli Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent Int. J. Nanomed. 7 2012 2007 2017
2. H.M. Ali, J. Daniel, D.J. Kirby, A.R. Mohammed, and Y. Pirrie Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent J. Pharm. Pharmacol. 62 2002 1646 1655
3. C. Allen, N. Dos Santos, R. Gallagher, G.N. Chiu, Y. Shu, W.M. Li, S.A. Johnstone, A.S. Janoff, L.D. Mayer, M.S. Webb, and M.B. Bally Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) Biosci. Rep. 22 2002 225 250 (Pubitemid 35222733)
4. S.H. Baek, S.J. Park, S.E. Jin, J.K. Kim, C.K. Kim, and J.M. Hwang Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits Eur. J. Pharm. Biopharm. 72 2009 546 551
5. A.D. Bangham, M.W. Hill, and N.G.A. Miller Preparation and use of liposomes as models of biological membranes Methods Membr. Biol. 1 1974 61 68
6. G.V. Betageri, and D.L. Parsons Drug encapsulation and release from multilamellar and unilamellar liposomes Int. J. Pharm. 81 1992 235 241
7. K. Boland, K. Manias, and H. Perlmutter Specificity in recognition of amyloid-beta peptide by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells J. Biol. Chem. 270 1995 2802 2828
8. C. Chen, D. Han, C. Cai, and X. Tang An overview of liposome lyophilization and its future potential J. Control. Release 142 2010 299 311
9. M. Chesler Regulation and modulation of pH in the brain Physiol. Rev. 83 2003 1183 1221 (Pubitemid 37222271)
10. M. Cho, A. Niles, R. Huang, J. Inglese, C.P. Austin, T. Riss, and M. Xia A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker Toxicol. In Vitro. 22 2008 1099 1106
11. Y.E. Choonara, V. Pillay, V.M.K. Ndesendo, L.C. du Toit, P. Kumar, R.A. Khan, C.S. Murphy, and D.L. Jarvis Polymeric emulsion and crosslink mediated synthesis of super stable nanoparticles as sustained release anti-tuberculosis drug carriers Colloids Surf. B Biointerfaces 87 2011 243 254
12. J.L. Cummings Alzheimer's disease N. Engl. J. Med. 351 2004 56 67
13. A.G. De Boer, and P.J. Gaillard Drug targeting to the brain Ann. Rev. Pharmacol. Toxicol. 47 2007 323 355
14. A. Delacourte Tauopathies: recent insights into old diseases Folia Neuropathol. 43 2005 244 257 (Pubitemid 43109283)
15. D.C. Drummond, C.O. Noble, M.E. Hayes, J.W. Park, and D.B. Kirpotin Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development J. Pharm. Sci. 97 2008 4696 4740
16. T. Erkinjuntti Treatment options: the latest evidence with galantamine (ReminylR) J. Neurol. Sci. 203 2002 125 130 (Pubitemid 35287387)
17. A. Gabizon, and D. Papahadjopoulos Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proc. Natl. Acad. Sci. U. S. A. 85 1988 6949 6953
18. A.S. Gobin, R. Rhea, R.A. Newman, and A.B. Mathur Silk fibroin-coated liposomes for long-term and targeted drug delivery Int. J. Nanomed. l 2006 81 87
19. L.A. Greene, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. U. S. A. 73 1974 2424 2428
20. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 1993 201 215 (Pubitemid 23283973)
21. S. Hauptmann, U. Keil, I. Scherping, A. Bonert, A. Eckert, and W.E. Müller Mitochondrial dysfunction in sporadic and generic Alzheimers disease Exp. Gerontol. 41 2004 668 673
22. M. Heinrich, and H. Lee Teoh Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucasian knowledge J. Ethnopharmacol. 92 2004 147 162 (Pubitemid 38610095)
23. M.N. Hossen, K. Kajioto, H. Akita, M. Hyodo, T. Ishitsuka, and H. Harashima Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue J. Control. Release 147 2010 261 268
24. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 1 2006 297 315
25. X. Ke, J.H. Bei, Y. Zhang, and J. Li In vitro and in vivo evaluation of sanguinarine liposomes prepared by a remote loading method with three different ammonium salts Pharmazie 66 2011 258 263
26. C. Kirby, J. Clarke, and G. Gregoriadis Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro Biochem. J. 186 1980 591 598
27. A. Kowalska The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease Neurol. Neurochir. Pol. 38 2004 405 411
28. R.A. Kroll, and E.A. Neuwelt Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means Neurosurgery 42 1998 1083 1099
29. X. Liang, G. Mao, and K.Y. Ng Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy J. Colloid Interface Sci. 278 2004 53 62 (Pubitemid 39094475)
30. X. Liu, K. Xu, M. Yan, Y. Wang, and X. Zheng Protective effects of galantamine against Aβ induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic stress Neurochem. Int. 57 2010 588 599
31. M.M. Lozano, and M.L. Longo Microbubbles coated with disaturated lipids and DSPE-PEG2000: phase behaviour, collapse transitions, and permeability Langmuir 25 2009 3705 3712
32. B. Matharu, G. Gibson, R. Parsons, T.N. Huckerby, S.A. Moore, L.J. Cooper, R. Millichamp, D. Allsop, and B. Austen Galantamine inhibits beta amyloid aggregation and cytotoxicity J. Neurol. Sci. 280 2009 49 58
33. M.S. Mufamadi, V. Pillay, Y.E. Choonara, L.C. du Toit, G. Modi, D. Naidoo, and V.M.K. Ndesendo Review on composite liposomal technologies for specialized drug delivery J. Drug Deliv. 3 2011 939851 10.1155/2011/939851
34. M.S. Mufamadi, Y.E. Choonara, P. Kumar, G. Modi, D. Naidoo, V.M.K. Ndesendo, L.C. du Toit, S.E. Iyuke, and V. Pillay Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with -amyloid aggregates of Alzheimer's disease Pharm. Res. 29 2012 3075 3089
35. K. Nakano, Y. Tozuka, and H. Takeuchi Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells Int. J. Pharm. 354 2008 174 179 (Pubitemid 351400326)
36. W.M. Pardridge Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain Curr. Opin. Drug Discov. Devel. 6 2003 683 691 (Pubitemid 37287937)
37. S. Patel, X. Zhang, L. Collins, and J.W. Fabre A small, synthetic peptide for gene delivery via the serpin-enzyme complex receptor J. Gene Med. 3 2001 271 279 (Pubitemid 33684775)
38. D.H. Perlmutter, G.I. Glover, M. Rivetna, C.S. Schasteen, and R.J. Fallon Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes Proc. Natl. Acad. Sci. U. S. A. 87 1990 3753 3757
39. D.H. Perlmutter, G. Josli, P. Nelson, C. Schasteen, S.P. Adams, and R.J. Fallon Endocytosis and degradation of alpha 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor J. Biol. Chem. 265 1990 16713 16716
40. C. Roney, P. Kulkarni, V. Arora, P. Antich, F. Bonte, A. Wu, N.N. Mallikarjuana, S. Manohar, H. Liang, A.R. Kulkarni, H.W. Sung, M. Sairam, and T.M. Aminabhavi Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease J. Control. Release 108 2005 193 214 (Pubitemid 41608654)
41. V. Rousseau, B. Denizot, J.J. Le Jeune, and P. Jallet Early detection of liposome brain localization in rat experimental allergic encephalomyelitis Exp. Brain Res. 125 1999 255 264 (Pubitemid 29134811)
42. L.L. Rubin, and J.M. Staddon The cell biology of the blood brain barrier Ann. Rev. Neurosci. 22 1999 11 28 (Pubitemid 29144879)
43. G.L. Scherphof, J. Dijkstra, H.H. Spanjer, J.T. Derksen, and F.H. Roerdink Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vitro and in vivo Ann. N.Y. Acad. Sci. 446 1985 368 384 (Pubitemid 16238580)
44. A. Schnyder, and J. Huwyler Drug transport to brain with targeted liposomes NeuroRx 2 2005 99 107 (Pubitemid 40128030)
45. R.D. Shytle, T. Mori, M. Vendrame, N. Sun, J. Zeng, J. Ehrhart, A.A. Silver, P.R. Sanberg, and J. Tan Cholinergic modulation of microglial activation by alpha7 nicotinic receptors J. Neurochem. 89 2004 337 343 (Pubitemid 38495982)
46. D. Simonis, M. Schlesinger, C. Seelandt, L. Borsig, and G. Bendas Analysis of SM4 sulfatide as a P-selectin ligand using model membranes Biophys. Chem. 150 2010 98 104
47. S. Song, D. Liu, J. Peng, Y. Sun, Z. Li, J.R. Gu, and Y. Xu Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo Int. J. Pharm. 363 2008 155 161
48. R. Suzuki, T. Takizawa, Y. Negishi, K. Hagisawa, K. Tanaka, K. Sawamura, N. Utoguchi, T. Nishioka, and K. Maruyama Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound J. Control. Release 117 2007 130 136 (Pubitemid 46161862)
49. R. Suzuki, T. Takizawa, Y. Kuwata, M. Mutoh, N. Ishiguro, N. Utoguchi, A. Shinohara, M. Eriguchi, H. Yanagie, and K. Maruyama Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome Int. J. Pharm. 346 2008 143 150 (Pubitemid 350101994)
50. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2 2005 145 160 (Pubitemid 40282557)
51. V.P. Torchilin Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers Adv. Drug Deliv. Rev. 60 2008 548 558 (Pubitemid 351215572)
52. B. Vaidya, M.K. Nayak, D. Dash, G.P. Agrawal, and S.P. Vyas Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents Int. J. Pharm. 403 2011 254 261
53. P.R. Veerareddy, and V. Vobalaboina Lipid-based formulations of amphotericin B Drugs Today 40 2004 133 145 (Pubitemid 38387618)
54. D.D. Verma, S. Verma, G. Blume, and A. Fahr Particle size of liposomes influences dermal delivery of substances into skin Int. J. Pharm. 258 2003 141 151 (Pubitemid 36712878)
55. Y. Wang, S. Tu, R. Li, X. Yang, L. Liu, and Q. Zhang Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior Nanomedicine 6 2010 471 477
56. M.C. Woodle, and D.D. Lasic Sterically stabilized liposomes Biochim. Biophys. Acta 1113 1992 171 199
57. N. Yagi, Y. Ogawa, M. Kadaka, T. Okada, T. Tomohiro, T. Konakahara, and H. Okuno Preparation of functional liposomes with peptide ligands and their binding to cell membranes Lipids 35 2000 673 680
58. A. Yamada, Y. Taniguchi, K. Kawano, T. Honda, Y. Hattori, and Y. Maitani Design of folate-linked liposomal doxorubicin to its antitumor effect in mice Clin. Cancer Res. 14 2008 8161 8168
59. X. Ying, H. Wen, W. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
60. A. Yousefi, F. Esmaeili, S. Rahimian, F. Atyabi, and R. Dinarvand Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel Sci. Pharm. 77 2009 453 464
61. B.H.C. Yu, H.C. Tai, W. Xue, L.J. Lee, and R.J. Lee Receptor targeted nanocarriers for therapeutic delivery to cancer Mol. Membr. Biol. 27 2010 286 298
62. J. Zhua, J. Xue, Z. Guo, and R.E. Marchant Vesicle size and stability of biomimetic liposomes from 3′-Sulfo-Lewis a (SuLea)-containing glycolipids Colloids Surf. B. Biointerfaces 58 2 2007 242 249 (Pubitemid 46921463)
63. A.G. Ziady, J.C. Perales, T. Ferkol, T. Gerken, H. Beegen, D.H. Perlmutter, and P.B. Davis Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor Am. J. Physiol. 273 1997 545 552